Zobrazeno 1 - 10
of 58
pro vyhledávání: '"D W Warnock"'
Publikováno v:
Medical Mycology. 38:293-304
Publikováno v:
Medical Mycology. 38:293-304
Publikováno v:
Journal of Clinical Pathology. 49:95-99
Publikováno v:
Journal of Antimicrobial Chemotherapy. 35:213-226
Autor:
B Dupont, P F Troke, M A Pfaller, A Espinel-Ingroff, T J Walsh, D W Warnock, J Müller, S Shadomy, M G Rinaldi, G S Kobayashi
Publikováno v:
Antimicrobial Agents and Chemotherapy. 36:1805-1809
An international collaborative study of broth dilution (MIC) and disk diffusion susceptibility testing of fluconazole was conducted by using a chemically defined medium (High-Resolution Antifungal Assay Medium; Oxoid Ltd., Basingstoke, United Kingdom
Publikováno v:
Clinical Drug Investigation. 13:118-120
Autor:
D. Elizabeth, D. W. Warnock, Arvind A. Padhye, D. Arjundas, S Verghese, P. Padmaja, K. C. Krishnakumar
Publikováno v:
Medical mycology. 40(3)
We describe a fatal case of imported coccidioidomycosis in India in a 22-year-old male who worked in Tucson, Arizona, approximately four years prior to his illness. The diagnosis was based on the presence of characteristic spherules with endospores i
Publikováno v:
Medical mycology. 38
As new antifungal agents are introduced for the treatment of infections caused by yeasts and filamentous fungi (moulds), it is important that reliable methods are available for the in vitro testing of both new and established agents. The ultimate goa
Publikováno v:
British journal of haematology. 105(4)
Fluconazole is widely used as antifungal prophylaxis but it is ineffective against Aspergillus. Itraconazole has a broader spectrum of activity but the capsules give erratic bioavailability in neutropenic patients. We compared itraconazole oral solut
Autor:
E C, Williamson, M R, Millar, C G, Steward, J M, Cornish, A B, Foot, A, Oakhill, D H, Pamphilon, B, Reeves, E O, Caul, D W, Warnock, D I, Marks
Publikováno v:
British journal of haematology. 104(3)
This study retrospectively reviews infections over a 7-year period in 60 consecutive adults (median age 25 years) undergoing their first unrelated donor bone marrow transplant (UD-BMT). T-cell depletion was employed in 93%. More than half the patient